Hans W. Nijman

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

H. Putter, T. Bosse, D. Cibula, 2020, International Journal of Gynecological Cancer.